Eli Lilly and Company (SWX:LLY)
640.00
+10.00 (1.59%)
At close: Oct 21, 2025
Eli Lilly and Company Market Cap
Eli Lilly and Company has a market cap or net worth of 570.42 billion as of October 21, 2025. Its market cap has decreased by -16.96% in one year.
Market Cap
570.42B
Enterprise Value
599.10B
Revenue
42.36B
Ranking
n/a
PE Ratio
51.98
Stock Price
640.00
Market Cap Chart
Since July 9, 1970, Eli Lilly and Company's market cap has increased from 3.09B to 570.42B, an increase of 18,356.59%. That is a compound annual growth rate of 9.89%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 21, 2025 | 570.42B | -9.44% |
Dec 31, 2024 | 629.92B | 42.70% |
Dec 29, 2023 | 441.43B | 37.33% |
Dec 30, 2022 | 321.43B | 40.80% |
Dec 31, 2021 | 228.28B | 68.57% |
Dec 31, 2020 | 135.43B | 10.81% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Roche Holding AG | 241.29B |
Novartis AG | 201.60B |
Lonza Group AG | 38.84B |
Galderma Group AG | 32.86B |
Alcon | 29.62B |
Sandoz Group AG | 21.08B |
Straumann Holding AG | 13.98B |
Sonova Holding AG | 13.05B |